<DOC>
	<DOCNO>NCT01562834</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial ass effect somatropin ( NorditropinÂ® ) replacement therapy leave ventricular mass adult patient growth hormone deficiency .</brief_summary>
	<brief_title>Effect Somatropin Left Ventricular Mass Growth Hormone Deficient Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Childhood adult onset growth hormone deficiency ( GHD ) GHD evidence two stimulation test Duration GHD least 5 year Other hormone deficiency associate growth hormone deficiency Pregnancy pregnancy desire suggest duration study Personal history colonic polyp family history colonic polyposis Known insulindependent noninsulindependent diabetes Cardiovascular disease , leave ventricular hypertrophy aetiology , recent auricular ventricular arrhythmia , history vascularisation aortocoronary bypass significative mitral aortic valvular disease , preexcitation syndrome , auriculoventricular conduction delay , bradycardiatachycardia syndrome , leave ventricular mass interfere treatment BMI ( Body Mass Index ) least 30 Growth hormone treatment 24 month prior inclusion , history treatment extractive pituitary growth hormone , allergy suspect allergy somatropin therapy Patient participate different clinical study within past two month Any condition , opinion Investigator Scientific Committee , may interfere successful implementation study Notion breast cancer mother sister</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>